Influenza Virus Vaccine Articles & Analysis
27 articles found
We built a more than 700,000-cubic-foot vaccine storage solution for a global manufacturer, during COVID-19 lockdown, on time and on budget. ...
For centuries outbreaks of numerous diseases called pandemics would plague human populations in large regions or even world-wide. Throughout history there have been a number of widespread pandemics the most devastating being the Black Death pandemic that killed over 75 million people in the 1350’s and the latest being influenza outbreaks, also known as the Spanish flu, in 1918 and ...
Currently, there are 133 candidate virus vector vaccines under development, and in particular, adenovirus vectors (82) have been widely used to develop vaccines for diseases such as Ebola, HIV, influenza and COVID-19. ...
Infectious diseases seriously threaten human health, and various infectious diseases may cause millions of severe cases and even death every year. Vaccination has been one of the most effective public health interventions in history, preventing millions of deaths worldwide. However, the success of vaccines relies not only on the antigens they carry but also on additional components known as ...
Meet D, one of CSL Seqirus’ Senior Regional Account Managers by day and international lacrosse coach by night. His network of health care system accounts across Northern Texas, Oklahoma and New Mexico know him as D, their Senior Regional Account Manager, but he also goes by Coach D. Why? Because outside of supporting his region’s vaccination needs at CSL Seqirus, leading ...
Infectious diseases like influenza can be threats to public health and our economy. At the OPTIONS XI for the Control of Influenza conference, leading influenza vaccines provider CSL Seqirus, joined academic, government, research and industry stakeholders to discuss and learn more about influenza and its impact. Below, CSL Seqirus shared additional insights into topics of interest to the ...
“We’re also battling the trolls and conspiracy theorists that push misinformation and undermine the outbreak response.” Vaccine-preventable diseases like COVID-19 and influenza continue to pose a significant public health threat. Vaccination is critical to protecting communities and reducing their spread. Although, with an ...
MADISON, Wis., Sept. 7, 2022 /PRNewswire/ — FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced the completion of enrollment of the first cohort in an age de-escalation clinical trial of M2SR (M2 Deficient Single Replication) live virus vaccine, ...
School is back in session, here’s what you need to know to help keep your family protected from flu. Influenza can be a real burden. It can spread rapidly between children and their families to have a significant impact on quality of life and disruption of usual activities: resulting in missed school days and for caregivers, missed work and illness themselves. So, here are a few ...
In 2022, flu cases in Australia have spiked earlier and with more cases this season than the previous five for the same time period. Experts discuss global implications of the surge. “Influenza is definitely back in the Southern Hemisphere,” said Professor Ian Barr, Deputy Director of The World Health Organization Collaborating Centre for Reference and Research on Influenza, ...
Using influenza virus as a model virus, the team established the technology of protein degradation targeting virus as an attenuated vaccine (Proteolysis-Targeting Chimeric virus vaccine, PROTAC vaccine), which provides new ideas for vaccine ...
CSL Seqirus delivered a record 135 million doses of flu vaccines globally last year, here’s how we make such a feat happen. Influenza vaccine manufacturing is an intricate and complex process that culminates in the summer months, when U.S. flu vaccine manufacturers receive regulatory approval from the FDA for the season’s vaccines. The manufacturers then prepare to distribute ...
Tab Lassiter – an employee of global vaccines leader CSL Seqirus – is about to receive a second transplant in an ongoing battle with a heart condition. He shares his story to explain why it’s critical to spread the word about heart health. Tab Lassiter once spent eight months resting anxiously in a hospital bed with cardiomyopathy, a condition that can lead to heart ...
Why we can’t overlook influenza in the midst of the ongoing COVID-19 pandemic. In many parts of the world, public health authorities are lifting social distancing, mask wearing and other COVID-19 mitigation measures in response to subsiding or stabilizing infection rates. But as daily life slowly returns to normal – and in the absence of an effective call to action on getting ...
Making influenza vaccines that can help protect against viruses that threaten human health isn’t a simple process. It requires the cooperation between influenza vaccine manufacturers like Seqirus, and the World Health Organization’s (WHO) 158 laboratories in 127 countries and 7 collaborating centers that comprise its ...
“This study is important, as it is the first of its kind to combine intranasal vaccine delivery with intramuscular shots to determine the potential for boosting vaccine efficacy and reducing transmission and virus ...
COVID-19 and viruses are a concern for all of us. Yet, anticipating a virus’s impact on an unborn child has heightened during the coronavirus pandemic for pregnant women or those expecting. However, there are tips you can take to protect yourself from viruses. ...
As the COVID-19 pandemic continues across the world, it’s more important than ever to get a flu vaccine, as some predict natural immunity to be decreased following last year’s lockdowns.[i] To make sure influenza vaccinations are effective, they must be stored at the proper temperature. At the end of the cold chain, safe vaccine storage can only be assured through quality ...
A breakthrough in nanotechnology accelerates vaccine production While COVID-19 hotspots have continued to emerge driven by the Delta variants, the data still shows that vaccinations are effective at preventing hospitalizations and deaths. While over 4 billion vaccine doses have been administered worldwide, only 27% of the world’s population and only 1.1% of people in low-income countries ...
This is believed to be the first demonstration of vaccine-induced protection against a highly drifted H3N2 influenza virus in a human challenge study. “Current vaccines are strain-specific and in recent years they have had low efficacy against H3N2 influenza, especially when the vaccine is ...